Search

everythinglearnresearchcommunity

for

Search:↓

Combining irinotecan and cetuximab is effective for some metastatic colorectal cancer patients but often causes manageable skin issues.

Cancer treatments can cause various eye problems, so eye doctors should know how to diagnose and treat these early.

Erlotinib can cause hair loss as a side effect.

Aumolertinib is effective and well-tolerated for treating advanced lung cancer with EGFR mutations.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Selumetinib significantly reduced tumor size and improved vision in a child with neurofibromatosis type 1.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

MK-5108 is safe and shows potential against tumors, especially alone.

Patients on dabrafenib and trametinib for melanoma often experience skin side effects.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.

Vemurafenib can cause scalp issues but can be managed without changing the dose.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Targeted therapies for advanced skin cancer often cause hair and nail problems, which need managing to avoid changing the treatment dose.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Cetuximab can cause eyelash growth, which is rare but manageable.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.